1. Jacque L. Duncan J.L . et al. and the Foundation Fighting Blindness Scientific Advisory Board; Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps. / Trans. Vis. Sci. Tech. – 2018. –Vol.7. №4.-P.6. 2. Офтальмология: руководство Наследственные дистрофии сетчатки, пигментного эпителия и хориоидеи. / Нероев В.В., Шамшинова А.М.. – М.: ГЭОТАР-Медиа, 2008. – С.548—565. 3. American Academy of Ophthalmology. Recommendations on Clinical Assessment of Patients with Inherited Retinal Degenerations. – 2016. Available at: https://www.aao.org/clinical-statement/recommendations-on-clinical-assessment-ofpatients. [Электронный источник]. 4. Шамшинова А.М., Зольникова И.В. Молекулярно-генетические основы патогенеза наследственных дистрофий сетчатки ./ Медицинская генетика.- 2004. - С.160-169. 5. Daiger S.P. et al. RetNet, the Retinal Information Network. – 2021. 6. Verbakel SK. et al. Non-syndromic retinitis pigmentosa. / ProgRetin Eye Res. – 2018 Sep; 66:157-186. 7. Berger W. et al. The molecular basis of human retinal and vitreoretinal diseases./ ProgRetin Eye Res.- 2010 Sep; 29(5):335-75. 8. Cremers, F.P.M. et al. Special Issue Introduction: Inherited Retinal Disease: Novel Candidate Genes, Genotype–Phenotype Correlations, and Inheritance Models. / Genes. – 2018. – Vol. 9. – P. 215. 9. Allikmets R. et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. / NatGenet. – 1997. – 15:236–46 . 10. Schulz, H. L. et al Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs. / Investigativeophthalmology&visualscience – 2017. – Vol. 8. № 1. – P. 394-403. 11. Johnson, A. A. et al. Bestrophin 1 and retinal disease. / Progress in retinal and eye research. – 2017 . – Vol. 58. – P. 45–69. 12. den Hollander AI. et al. Leber congenital amaurosis: genes, proteins and disease mechanisms. / ProgRetin Eye Res. – 2008. – Vol. 27 № 4. – P. 391–419. 13. Leroy BP et al. Leber congenital amaurosis due to CEP290 mutations-severe vision impairment with a high unmet medical need: A Review. / Retina. – 2021 May 1. – Vol. 41 № 5. – P. 898-907. 14. Hamel C. P. Cone rod dystrophies. / Orphanet journal of rare diseases. – 2007. – Vol. 2 № 7. 15. AAO. Retinitis pigmentosa.https://eyewiki.org/Retinitis_Pigmentosa. [Электронный источник]. Дата доступа: 8.11.2021. 16. AAO. Stargardt_ disease/Fundus flavimaculatus.https://eyewiki.aao.org/Stargardt_ disease/Fundus flavimaculatus) [Электронный источник]. Дата доступа: 8.11.2021. 17. AAO. Best Disease and Bestrophinopathies. https://eyewiki.aao.org/Best Disease and Bestrophinopathies- [Электронный источник]. Дата доступа: 8.11.2021 33 18. Fujiwara K. et al. Risk Factors for Posterior Subcapsular Cataract in Retinitis Pigmentosa. / Invest Ophthalmol Vis Sci. – 2017 May 1. – Vol. 58 № 5. – P. 2534-2537. doi: 10.1167/iovs.17-21612. PMID: 28492871. 19. Зольникова И.В, Рогатина Е.В. Дистрофия Штаргардта: клиника, диагностика, лечение. / Клиницист. – 2010. – № 1. – С. 29-33. 20. Зольникова И.В., Рогатина Е.В., Орловская Л.С., Пономарева Е.Н. Мультифокальная, макулярная и паттерн-ЭРГ при вителлиформноймакулодистрофии Беста / Офтальмология. – 2006. – Т.3. №.2. – С. 29-36. 21. Chowers I.et al.Chowers I. et al. Adult-onset foveomacularvitelliform dystrophy: A fresh perspective. / ProgRetin Eye Res. – 2015 Jul. – Vol. 47. – P. 64-85. https://retinagene.ru/files/Брошюра.pdf 22. McMahonTimothy T.; et al. CRB1 Gene Mutations Are Associated with Keratoconus in Patients with Leber Congenital Amaurosis. / Investigative Ophthalmology & Visual Science. - 2009 July. – Vol.50. - P. 3185-3187. 23. Bittner A. K. et al. Characteristics and Possible Visual Consequences of Photopsias as Vision Measures Are Reduced in Retinitis Pigmentosa. / Invest. Ophthalmol. Vis. Sci. – 2011. – Vol. 52. № 9. – P. 6370-6376. doi: https://doi.org/10.1167/iovs.11-7195.). 24. Saihan Z. et al. Update on Usher syndrome. / CurrOpin Neurol. – 2009. – Vol. 22. № 1. – P. 19-27. 25. Metzker M. Sequencing technologies — the next generation. (англ.) / Nature Reviews Genetics. — 2010. — No. 11. — P. 31—46. 26. Weiss G. J. et al. A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges. (англ.) / PLoS ONE. — 2013. — 30 October. – Vol. 8. № 10. — doi:10.1371/journal.pone.0076438 27. Grover S, et al. Visual acuity impairment in patients with retinitis pigmentosa. / Ophthalmology. – 1996 Oct. – Vol. 103. № 10. – P. 1593-600. 28. Rotenstreich Y. et al. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. / Ophthalmology. – 2003 Jun. – Vol. 110. №6. – P. 1151- 8. 29. Fishman GA et al. Visual acuity in patients with best vitelliform macular dystrophy. / Ophthalmology. – 1993 Nov. – Vol. 100. № 11. – P. 1665-70. 30. Walia S. et al. Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. / Ophthalmology. – 2010. – Vol. 117. № 6. – P. 1190-8. 31. Hamel C. P. Cone rod dystrophies. / Orphanet journal of rare diseases. – 2007. – 2, P.7. 32. Sieving, P. A., & Fishman, G. A. Refractive errors of retinitis pigmentosa patients. / TheBritishjournalofophthalmology. - 1978. – Vol. 62. № 3. – P. 163–167. 33. Hendriks M. et al. CCW. Development of Refractive Errors-What Can We Learn From Inherited Retinal Dystrophies? / Am J Ophthalmol. – 2017 Oct. – Vol. 182. – P. 81-89. 34. Hong Y. et al. A Review of Complicated Cataract in Retinitis Pigmentosa: Pathogenesis and Cataract Surgery. / J Ophthalmol. – 2020 Dec 21. – 2020:6699103. 35. Liew G. et al. Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa. / British Journal of Ophthalmology. – 2019. – Vol. 103. № 8. – P. 1163–1166. 34 36. K. Fujiwara et al. Risk factors for posterior subcapsular cataract in retinitis pigmentosa. / Investigative Opthalmology& Visual Science. – 2017. – Vol. 58. № 5. – P. 2534–2537. 37. Strong S. et al. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. / Br. J. Ophthalmol. – 2017. – Vol. 101. №1. – P. 31–7. 38. Зольникова И.В. Современные электрофизиологические и психофизические методы диагностики при дистрофиях сетчатки (обзор литературы). / Офтальмохирургия и терапия. – 2004. – Т. 2. – С. 30–40 39. Mäntyjärvi M, Tuppurainen K. Color vision in Stargardt's disease. / Int Ophthalmol. – 1992 Nov. – Vol. 16. № 6. – P. 423-8. 40. Xu, M., Zhai, Y., & MacDonald, I. M. Visual Field Progression in Retinitis Pigmentosa. / Investigative ophthalmology & visual science. – 2020. – Vol. 61. №6. – P. 56. 41. Abalem, M. F. et al. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence. / Americanjournalofophthalmology. – 2017. – Vol. 184. – P. 181–188. 42. Birch D.G. et al. Rod ERGs in retinitis pigmentosa and cone-rod degeneration. / Invest Ophthalmol Vis Sci. – 1987. PMID: 3804644 43. Зольникова И.В. Мультифокальная и хроматическая макулярнаяэлектроретинограмма в диагностике пигментного ретинита. / Вестник новых медицинских технологий. – 2009. – Т. 16. № 3. – С. 171-174. 44. Seeliger M. et al. Multifocal electroretinography in retinitis pigmentosa. / Am J Ophthalmol. – 1998. – Vol. 125. – P. 214. 45. Зольникова И.В., Карлова И.З., Рогатина Е.В. Макулярная и мультифокальная электроретинография в диагностике дистрофии Штаргардта. / Вестник офтальмологии. – 2009. – Т. 125. № 1. – С. 41-6. 46. Lachapelle P. et al. The electroretinogram in Stargardt's disease and fundus flavimaculatus. / DocOphthalmol. – 1989 Dec. – Vol. 73. № 4. – P. 395-404. 47. Brecelj J, Stirn-Kranjc B. ERG and VEP follow-up study in children with Leber's congenital amaurosis. / Eye (Lond). – 1999. – Vol. 13 ( Pt 1). – P. 47-54. 48. Langwińska-Wośko E. et al. Electrophysiological testing as a method of cone-rod and cone dystrophy diagnoses and prediction of disease progression. / Doc Ophthalmol. – 2015 Apr. – Vol. 130. № 2. – P. 103-9. 49. Зольникова И.В., Милаш С.В., Черняк А.Б., Левина Д.В., Егорова И.В., Рогатина Е.В., Еремеева Е.А., Рогова С.Ю. Толщина фоторецепторных слоев сетчатки, хориоидеи и биоэлектрическая активность макулярной области при пигментном ретините. / Вестник офтальмологии. – 2019. – С. 39-45. 50. Зольникова И.В., Милаш С.В., Черняк А.Б., Левина Д.В., Егорова И.В., Рогатина Е.В., Еремеева Е.А., Рогова С.Ю. Постфоторецепторные слои сетчатки и макулярная электроретинограмма при пигментном ретините. / Офтальмология. – 2020. – Т. 17. № 1. – С. 81-87. 51. Liu G. et al. Optical Coherence Tomographic Analysis of Retina in Retinitis Pigmentosa Patients. / Ophthalmic Res. – 2016. – Vol. 56. – P. 111-122. 52. Oh J.K. et al. Optical coherence tomography in the evaluation of retinitis pigmentosa. / Ophthalmic Genet. – 2020 Oct. – Vol. 41. № 5. – P. 413-419. 53. Poornachandra B. et al. Quantifying microstructural changes in retinitis pigmentosa using spectral domain – optical coherence tomography. / Eye and Vis. – 2019. – Vol. 6. – P. 13. 35 54. Hirakawa H. et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. / Am J Ophthalmol. – 1999 – Vol. 128. № 2. – P. 185-91. 55. Apushkin M.A. et al. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. / Ophthalmology. – 2004. 1111899- 1904. 56. Hajali M. et al.. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. / Br J Ophthalmol.-2008.-Vol.92.- P.1065–8. 57. Makiyama Y. et al. Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography./ Retina. – 2014. – Vol.34.-№5. – P.981-8. 58. Ikeda Y. et al. Long-term Surgical Outcomes of Epiretinal Membrane in Patients with Retinitis Pigmentosa. / Sci Rep. – 2015. Vol. 5.-P.13078. 59. Tanna P. et al Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options / Br J Ophthalmol. -2017. –Vol.101. –P.25-30. 60. Battaglia P. et al. Spectral domain optical coherence tomography features in different stages of best vitelliform macular dystrophy./ Retina.-2018. –Vol.38. - №5. – P.1041- 1046. 61. Kumaran N. et al.. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. / Br J Ophthalmol. – 2017. – Vol.101. -№9.- P.:1147-1154. 62. Birtel J. et al.. Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy. / Sci Rep. -2018. Vol. 8.-P.4824. 63. Thiadens A. A. et al. Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy. / Ophthalmology.-2012- Vol.119.- P. 819–826. 64. Катаргина Л.А., Денисова Е.В., Арестова Н.Н., Круглова Т.Б., Осипова Н.А., Новикова О.В. ОКТ-ангиография в диагностике и мониторинге болезни Беста. / Офтальмология. – 2019. – Vol.16. -,№1S. P.79–84. 65. Lima L.H. et al. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. / Retina. 2009. – Vol. 29. №7.- P: 1025–31. 66. Popovic P. et al. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa./ Graefes Arch Clin Exp Ophthalmol.- 2005. - Vol 243.- P. 1018-1027. 67. Милаш С.В., Зольникова И.В., Кадышев В.В. Мультимодальная визуализация наследственных дистрофий сетчатки (серия клинических случаев). Российский офтальмологический журнал./ 2020. – Vol.13. -№4. – P.75-82. 68. Tsang S.H., Sharma T. Leber Congenital Amaurosis. / Adv Exp Med Biol. – 2018. – Vol.1085. –P.131-137. 69. Querques G. et al.. High definition optical coherence tomography features in vitelliform macular dystrophy./ Am J Ophthalmol. -2008. – Vol.146. P.501–7. 70. Park E.A. et al.. Peripheral Leakage on Ultra-Widefield Fluorescein Angiography in Patients With Inherited Retinal Degeneration. // Journal of VitreoRetinal Diseases. -2021. – Vol.5. - №2.- P.147-156. 71. Russell S. et al. Efficacy and safety of voretigeneneparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. / Lancet. 2017. – Vol.390 - 10097. P.849-860. 36 72. Tuohy G.P., Megaw, R. A. Systematic Review and Meta-Analyses of Interventional Clinical Trial Studies for Gene Therapies for the Inherited Retinal Degenerations (IRDs)./ Biomolecules. – 2021. – Vol. 11.- P.760. 73. Chung D.C. et al. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene. / Am J Ophthalmol. – 2019. Vol.199.- P.58-70. 74. Kumaran N. et al. Retinal Structure in RPE65-Associated Retinal Dystrophy. / Invest Ophthalmol Vis Sci. – 2020. – Vol.61. - №4. P.47. 75. Cicinelli M.V. et al. Monitoring and Management of the Patient with Stargardt Disease./ ClinOptom (Auckl).- 2019. Vol. 11. P.151-165. 76. Waugh N. et al.. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review. / Health Technol Assess. -2018. -Vol.27. - P.1-168. 77. Berson, E. L., et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. /- Archives of ophthalmology. 2010. – Vol. 128. - №4. – P.403–411. 78. Berson E.L. et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. / Arch Ophthalmol. – 2004. Vol.122.- P.1297- 1305. 79. Schwartz S.G. et al. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa. / Cochrane Database Syst Rev. – 2020.- Vol. 18. №6. :CD008428. 80. Federspiel C.A. et al. (2018) Vitamin A in Stargardt disease—an evidence-based update / Ophthalmic Genetics,- 2018. –Vol.39. №:5. P. 555-559, 81. Berson E.L. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa. / JAMA Ophthalmol. – 2018. Vol.136. №5. -P:490-495. 82. Weiss N.J. Low vision management of retinitis pigmentosa. / J Am Optom Assoc.- 1991 Vol.62. №1. P.42-52. 83. Fishman G.A. Retinitis pigmentosa. Visual loss. / Arch Ophthalmol. 1978. – Vol.96. - №7. P.1185-1188. 84. Fishman G.A., et al.. X-linked retinitis pigmentosa. Profile of clinical findings. / Arch Ophthalmol. -1988. Vol106. №3.- P.:369-375. 85. Основы курортологии. Частная курортотерапия. Под редакцией В.А.Александрова. Санаторно-курортное лечение глазных заболеваний.С.И. Тальковский. Москва.Медгиз., 1958г.- с.327-344.